Accolade Inc. (ACCD)
NASDAQ: ACCD
· Real-Time Price · USD
7.02
0.00 (0.00%)
At close: Apr 07, 2025, 3:59 PM
Accolade Revenue Breakdown
Period Ending | Feb 29, 2024 | Feb 28, 2023 |
---|---|---|
Access fees Revenue | 300.49M | 284.14M |
Access fees Revenue Growth | +5.75% | n/a |
Health Care, Patient Service Revenue | 113.8M | n/a |
Health Care, Patient Service Revenue Growth | n/a | n/a |
Operating Expense Breakdown
Period Ending | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 41.71M | 41.47M | 44.2M | 39.04M | 41.7M | 40.34M | 41.11M | 43.45M | 45.06M | 45.96M | 45.85M | 53.1M | 46.08M | 50.18M | 36.51M | 20.92M | 17.06M | 14.33M | 12.98M | 12.88M | 16.48M | 13.63M | 13.22M | 11.28M | 11.4M |
Selling, General, and Administrative Revenue Growth | +0.58% | -6.19% | +13.23% | -6.39% | +3.39% | -1.89% | -5.39% | -3.56% | -1.95% | +0.23% | -13.65% | +15.24% | -8.17% | +37.44% | +74.55% | +22.62% | +19.00% | +10.41% | +0.82% | -21.84% | +20.90% | +3.04% | +17.27% | -1.04% | n/a |
Research and Development Revenue | 20.59M | 22.48M | 26.31M | 24.19M | 23.47M | 25.6M | 25.9M | 24.08M | 24.25M | 26.19M | 26.82M | 22.37M | 22.85M | 22.51M | 15.94M | 13.33M | 13.02M | 12.24M | 11.37M | 8.71M | 11.05M | 11.3M | 11.25M | 9.82M | 9.33M |
Research and Development Revenue Growth | -8.40% | -14.57% | +8.76% | +3.08% | -8.34% | -1.15% | +7.55% | -0.71% | -7.41% | -2.32% | +19.90% | -2.10% | +1.48% | +41.24% | +19.56% | +2.40% | +6.39% | +7.62% | +30.52% | -21.14% | -2.27% | +0.51% | +14.50% | +5.23% | n/a |
Sales and Marketing Revenue | 25.51M | 24.93M | 28.19M | 24.73M | 26.23M | 24.08M | 25.03M | 23.54M | 25.02M | 24.94M | 25.61M | 23.63M | 24.62M | 24.01M | 14.51M | 9.87M | 8.64M | 7.88M | 7.32M | 6.85M | 7.92M | 7.62M | 7.66M | 6.21M | 5.63M |
Sales and Marketing Revenue Growth | +2.31% | -11.57% | +14.02% | -5.73% | +8.95% | -3.82% | +6.34% | -5.93% | +0.35% | -2.65% | +8.39% | -4.00% | +2.53% | +65.48% | +47.00% | +14.18% | +9.68% | +7.74% | +6.82% | -13.58% | +4.04% | -0.60% | +23.34% | +10.42% | n/a |